NextPharma Technologies provides contract manufacturing services to biotechnology, pharmaceutical, diagnostic, and medical device companies. It is the US manufacturing facility of UK-based NextPharma Technologies Holding Ltd. Its facilities can prepare the small batches of biological drugs and placebos used in clinical trials. It can produce solid, liquid, and semi-solid products, as well as injectable drugs. It also offers clinical trial support services and pharmaceutical logistics services. The company's customers include both small and large multinational health care corporations. NextPharma Technologies Holding was acquired by the European arm of Sun Capital Partners in 2011.